KWALEP Trademark

Trademark Overview

On Wednesday, July 7, 2021, a trademark application was filed for KWALEP with the United States Patent and Trademark Office. The USPTO has given the KWALEP trademark a serial number of 79319135. The federal status of this trademark filing is REGISTERED as of Tuesday, December 6, 2022. This trademark is owned by KRINGLE PHARMA, INC.. The KWALEP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of nerve system diseases, renal disease, respiratory system diseases, skin diseases and scar tissue
kwalep

General Information

Serial Number79319135
Word MarkKWALEP
Filing DateWednesday, July 7, 2021
Status700 - REGISTERED
Status DateTuesday, December 6, 2022
Registration Number6914875
Registration DateTuesday, December 6, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 4, 567-0085 should be inserted.
Goods and ServicesPharmaceutical preparations for the treatment of nerve system diseases, renal disease, respiratory system diseases, skin diseases and scar tissue
Translation of Words in MarkThe wording "KWALEP" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKRINGLE PHARMA, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIbaraki- shi Osaka 567-0085
JP
Party NameKRINGLE PHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIbaraki- shi Osaka 567-0085
JP
Party NameKRINGLE PHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIbaraki- shi Osaka 567-0085
JP

Trademark Events

Event DateEvent Description
Tuesday, September 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 2, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, September 11, 2021APPLICATION FILING RECEIPT MAILED
Sunday, March 27, 2022ASSIGNED TO EXAMINER
Sunday, March 27, 2022NON-FINAL ACTION WRITTEN
Monday, March 28, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 6, 2022REFUSAL PROCESSED BY MPU
Friday, May 6, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, May 30, 2022REFUSAL PROCESSED BY IB
Thursday, July 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 7, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 7, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, December 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, December 28, 2022NOTIFICATION PROCESSED BY IB
Monday, March 6, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, March 24, 2023FINAL DISPOSITION PROCESSED
Friday, March 24, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, April 19, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, August 9, 2023TEAS SECTION 7 REQUEST RECEIVED
Monday, March 25, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 5, 2024CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, May 14, 2024NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

Related Keywords

kwalep diseases system skin respiratory scar tissue disease renal treatment nerve